Riskpilot← Back to searchSign inGet full accessOMB Medical AB
ABActiveOrg 5569250896Tideliusgatan 29General medical practice activities · NACE 8621Est. 20131 employees
Revenue 2024
SEK 2,5M
+17% vs 2023
EBITDA margin
31.0%
+100% vs 2023
Equity ratio
90.4%
Financial strength
Net profit 2024
SEK 732K
+134% vs 2023
| Revenue | SEK 2,5M | +17% |
| EBITDA | SEK 775K | +100% |
| Net profit | SEK 732K | +134% |
| Total assets | SEK 9,2M | +5% |
| Equity | SEK 8,3M | +2% |
| Employees | 1 | — |
Legal name
OMB Medical AB
Org number
5569250896
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 mars 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva medicinsk behandling samt utbildning och konsultation inom medicin.
Address
Tideliusgatan 29
Email
orlando.morales32@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 480 | 1 530 | 2 667 | 2 135 | 2 499 |
| Staff expenses | — | — | −1 548 | −1 408 | −1 466 |
| EBITDA | 1 408 | −216 | 1 055 | 387 | 775 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 408 | −216 | 1 055 | 387 | 775 |
| Net financials | −1 | −1 | 18 | 6 | 145 |
| Profit before tax | 1 906 | −217 | 1 073 | 393 | 920 |
| Tax | −412 | −0 | −177 | −80 | −188 |
| Net profit | 1 494 | −217 | 897 | 313 | 732 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 699 | 8 467 | 9 286 | 8 820 | 9 227 |
| Equity | 8 715 | 7 999 | 8 395 | 8 209 | 8 341 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 983 | 468 | 891 | 612 | 887 |
| Total debt | 983 | 468 | 891 | 612 | 887 |
EBITDA margin
31.0%
This company
15.8%
Market median
+96% vs market
20202024
Equity ratio
90.4%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
8.8%
This company
18.4%
Market median
-52% vs market
20202024
Net profit margin
29.3%
This company
8.1%
Market median
+262% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OMB Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Gabriel Lundgren | Audit | 0 companies |
| Hulda Eva Katarina Wickbom | Deputy Board Member | 0 companies |
| Orlando Morales Bustos | Board of Directors | 0 companies |